Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Criminal investigators in the US Homeland Security Investigations’ National Intellectual Property Rights Coordination Center have partnered with Pfizer, 3M, Citi, Alibaba, Amazon and Merck & Co to combat fraud and other illegal activity related to COVID-19.   6 May 2020
Americas
US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.   5 May 2020
Asia-Pacific
An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline subsidiary.   5 May 2020
Americas
3M has filed four more trademark lawsuits against companies accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic, while also securing a preliminary injunction in another suit.   5 May 2020
Big Pharma
Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.   1 May 2020
Biotechnology
The University of Oxford has partnered with UK pharmaceutical company AstraZeneca to develop and manufacture the university’s trial COVID-19 vaccine.   30 April 2020
Big Pharma
The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.   30 April 2020
Americas
Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.   30 April 2020
Big Pharma
Gilead has escalated its dispute with the US federal government by filing a new lawsuit accusing it of improperly filing for patents covering HIV drug Truvada.   29 April 2020
Americas
3M has filed another trademark infringement suit against what it’s called a “deplorable pandemic profiteer”, as the multinational seeks to stop the alleged price-gouging of N95 masks amid the COVID-19 outbreak.   29 April 2020